---

Procedure

Total hysterectomy and bilateral salpingo-oophorectomy Radical hysterectomy Simple hysterectomy Supracervical hysterectomy Bilateral salpingo-oophorectomy Right salpingo-oophorectomy Left salpingo-oophorectomy Salpingo-oophorectomy, side not specified Right oophorectomy Left oophorectomy Oophorectomy, side not specified Bilateral salpingectomy Right salpingectomy Left salpingectomy Salpingectomy, side not specified Omentectomy Peritoneal biopsies Peritoneal washing Other

---

Specimen Integrity

Intact Opened Morcellated Other

---

Tumor Size (cm)

---

Histologic Type (select all that apply)

Explanatory notes on tumor types Leiomyosarcoma Leiomyosarcoma, epithelioid type Leiomyosarcoma, myxoid type Endometrial stromal sarcoma, low grade Endometrial stromal sarcoma with smooth muscle differentiation, low grade Endometrial stromal sarcoma with sex cord elements, low grade Endometrial stromal sarcoma with glandular elements, low grade Endometrial stromal sarcoma, high grade Undifferentiated uterine/endometrial sarcoma Adenosarcoma Adenosarcoma with rhabdomyoblastic differentiation Adenosarcoma with cartilaginous differentiation Adenosarcoma with osseous differentiation Adenosarcoma with other heterologous element Adenosarcoma with sarcomatous overgrowth Rhabdomyosarcoma Malignant perivascular epithelioid cell tumor Other histologic type not listed

---

Other Tissue/ Organ Involvement

Not applicable Not identified Right ovary Left ovary Ovary (side not specified) Right fallopian tube Left fallopian tube Fallopian tube (side not specified) Vagina Right parametrium Left parametrium Parametrium (side not specified) Pelvic wall Omentum Other organs/tissue

---

Margins

Cannot be assessed Uninvolved by sarcoma Involved by sarcoma

---

Lymphovascular Invasion

Not identified Present Cannot be determined

---

+ Peritoneal/Ascitic Fluid

Not submitted/ unknown Negative for malignancy (normal/benign) Atypical and/or suspicious Malignant (positive for malignancy) Unsatisfactory/nondiagnostic Results pending

---

+ Ancillary Studies

---

Regional Lymph Nodes

Check here if any lymph nodes submitted?

---

Pathologic Staging (pTNM)

TNM Descriptors (select all that apply)

Not applicable r y

pT

pTX: Primary tumor cannot be assessed pT0: No evidence of primary tumor pT1a: Tumor 5 cm or less in greatest dimension pT1b: Tumor more than 5 cm pT2a: Tumor involves adnexa pT2b: Tumor involves other pelvic tissues pT3a: Tumor infiltrates abdominal tissues in one site pT3b: Tumor infiltrates abdominal tissues in more than one site pT4: Tumor invades bladder or rectum pTX: Primary tumor cannot be assessed pT0: No evidence of primary tumor pT1a: Tumor limited to the endometrium/endocervix pT1b: Tumor invades to less than half of the myometrium pT1c: Tumor invades one half or more of the myometrium pT2a: Tumor involves adnexa pT2b: Tumor involves other pelvic tissues pT3a: Tumor infiltrates abdominal tissues in one site pT3b: Tumor infiltrates abdominal tissues in more than one site pT4: Tumor invades bladder and/or rectum

pN

pNX: Regional lymph nodes cannot be assessed pN0: No regional lymph node metastasis pN0(i+): Isolated tumor cells in regional lymph node(s) no greater than 0.2 mm pN1: Regional lymph node metastasis

pM

pMx: Not applicable pM1: Distant metastasis (excluding adnexa, pelvic and abdominal tissues)